Top Stories
Top Stories
Biotech and Pharma

Eli Lilly cuts 2019 forecast on trial failure, Loxo deal

Key Points
  • Eli Lilly cut its 2019 profit forecast, hit by a recent trial failure of conditionally approved cancer treatment Lartruvo and costs related to its pending acquisition of Loxo Oncology.
  • Lilly said it now expects 2019 adjusted earnings per share of between $5.55 and $5.65, compared with an earlier forecast of $5.90 to $6.
  • For the full year, the company now expects revenue to be between $25.1 billion and $25.6 billion, compared with its prior forecast of $25.3 billion to $25.8 billion.
An Eli Lilly & Co. logo is seen on the cap of a pill bottle in this arranged photograph at a pharmacy in Princeton, Illinois.
Daniel Acker | Bloomberg | Getty Images

Eli Lilly cut its 2019 profit forecast on Wednesday, hit by a recent trial failure of conditionally approved cancer treatment Lartruvo and costs related to its pending acquisition of Loxo Oncology.

The company, which is focusing on cancer drugs, said last month it would buy Loxo Oncology Inc for $8 billion.

Lilly said it now expects 2019 adjusted earnings per share of between $5.55 and $5.65, compared with an earlier forecast of $5.90 to $6.00.

For the full year, the company now expects revenue to be between $25.1 billion and $25.6 billion, compared with its prior forecast of $25.3 billion to $25.8 billion.

The company posted net income of $1.13 billion, or $1.10 per share, in the fourth quarter ended Dec. 31, compared with a net loss of $1.66 billion, or $1.58 per share, a year earlier, when it recorded charges related to the U.S. tax overhaul.

Excluding items, it earned $1.33 per share, slightly below the average analyst estimate of $1.34 per share.

Revenue rose 4.5 percent to $6.44 billion, beating the average analyst estimate of $6.29 billion, according to IBES data from Refinitiv.

Next Article
Key Points
  • Spotify announced it is buying privately-held podcast companies Gimlet Media and Anchor.
  • The company said it plans to spend $400 million to $500 million in podcast acquisitions in 2019.
  • As of late last week, the deal with Gimlet was expected to close north of $200 million.